What's Going On With LianBio (LIAN) Stock?
What's Going On With LianBio (LIAN) Stock?
LianBio – ADR (NASDAQ:LIAN) shares are trading higher by some 84% to $0.35 Friday afternoon on continued volatility. The company in late February announced its intent to delist its American Depositary Shares (ADSs) from the Nasdaq Global Market. This decision, made following a strategic review by the Board of Directors, involves winding down operations and deregistering its ordinary shares and ADSs.
LianBio——由於持續波動，ADR（納斯達克股票代碼：LIAN）股價週五下午上漲約84％，至0.35美元。該公司在2月下旬宣佈打算將其美國存托股票（ADS）從納斯達克全球市場退市。該決定是在董事會進行戰略審查後做出的，涉及結束業務並註銷其普通股和ADS的註冊。
The company aims to reduce costs associated with regulatory compliance and management time, while returning value to shareholders through asset sales, out-licensing efforts, and dividends. Trading of ADSs post-delisting is expected to shift to privately negotiated sales and potentially an over-the-counter market.
該公司的目標是降低與監管合規和管理時間相關的成本，同時通過資產出售、向外許可和分紅向股東返還價值。退市後的ADS交易預計將轉向私下談判的銷售，並可能轉向場外交易市場。
LianBio shares have also seen volatility in recent weeks after the company completed its strategic review and determined to initiate the wind down of its operations, including the sale of remaining pipeline assets, delisting of ADS and workforce reductions. Also, the company declared a $4.80 special dividend.
最近幾周，LianBio的股價也出現了波動，此前該公司完成了戰略審查，並決定開始結束業務，包括出售剩餘管道資產、將ADS退市和裁員。此外，該公司還宣佈派發4.80美元的特別股息。
譯文內容由第三人軟體翻譯。